NCT00003816 arm group 11bce82bf184f649b806b2b0b3505219 [clinicaltrials_resource:NCT00003816/arm-group/11bce82bf184f649b806b2b0b3505219]
NCT00003816 arm group 11bce82bf184f649b806b2b0b3505219 [clinicaltrials_resource:NCT00003816/arm-group/11bce82bf184f649b806b2b0b3505219]
Bio2RDF identifier
NCT00003816/arm-group/11bce82bf184f649b806b2b0b3505219
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... bce82bf184f649b806b2b0b3505219
description [clinicaltrials_vocabulary:description]
Patients receive busulfan IV o ...... ver 2 hours on days -3 and -2.
identifier
clinicaltrials_resource:NCT00003816/arm-group/11bce82bf184f649b806b2b0b3505219
title
NCT00003816 arm group 11bce82bf184f649b806b2b0b3505219
@en
type
label
NCT00003816 arm group 11bce82b ...... ce82bf184f649b806b2b0b3505219]
@en